Chronic stable angina pectoris is a common manifestation of coronary artery disease, which is the leading cause of death worldwide. An estimated 15.5 million American adults have chronic coronary ...

Table 2 Summary of eligibility criteria of the COURAGE, BARI 2D, ... Inadequate response to optimal antianginal medical therapy. Comorbid conditions that limit optimal use of these drugs.

Intensive antianginal medical therapy can be ... The results of cardiovascular risk factor assessment are provided in Table S6. The median number of antianginal agents that were ...

For patients undergoing elective percutaneous coronary intervention (PCI), pretreatment with the antianginal agent ranolazine substantially reduces the risk of periprocedural myocardial infarction (MI ...

William B. Borden, MD, of Weill Cornell Medical College (New York, NY), and colleagues analyzed antianginal therapy use prior to 300,772 PCI procedures for stable CAD in the National Cardiovascular ...